• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 2 Device Recall Candela Corporation Vbeam Aesthetica Laser System

  • Print
  • Share
  • E-mail
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC

New Search Back to Search Results
 Class 2 Device Recall Candela Corporation Vbeam Aesthetica Laser System see related information
Date Posted February 15, 2007
Recall Status1 Terminated on February 03, 2014
Recall Number Z-0509-2007
Recall Event ID 37180
Product Classification Laser System - Product Code GEX
Product Candela Corporation Vbeam Aesthetica Laser System, Model/Catalog # 9914-08-0320 Vbeam Aesthetica w/ gray enclosure and gray display
Code Information 9914-0320-XXXXX, where XXXX = 0001 thru 0513 (a sequential # independent of it being a Perfecta, Platinum, or Aesthetica model)
Recalling Firm/
Candela Laser Corporation
530 Boston Post Rd
Wayland MA 01778-1833
For Additional Information Contact Ed Gramer
Manufacturer Reason
for Recall
Internal component may overheat causing the possibility of risk of fire or smoke
FDA Determined
Cause 2
Action Candela Corporation notified US consignees by letter (w/return receipt) identifying the potential problem on 1/17/2007. Candela services will contact the customers and schedule upgrades. International packages were sent to each distributor via Fed-x/DHL tracking on 1/17/2007. Distributors were asked to forward individual serial number packages to their customers. Upgrade material will be forwarded to distributors upon which they will schedule upgrades with their customers.
Quantity in Commerce 474 laser systems total (all models)
Distribution Worldwide including USA, Europe, Far East, Canada, Japan, Australia, Middle East, Mexico
Total Product Life Cycle TPLC Device Report

1 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.